An innovation-driven company
Developing patient-friendly, long-acting dosage forms
Making a difference in people’s lives
With unique oral extended-release products
Expand your market share
By offering new medications with oral extended-release capabilities
Offer innovative medications for children
With oral extended-release benefits in a non-tablet form
A proven track record of achievement
Developing long-acting dosage forms that meet market demands
Tris’ branded pharmaceutical business is focused on improving patients’ experiences by offering extended-release formulations for the pediatric market.
Our generics division develops products that leverage our proprietary technologies and strong R&D capabilities.
A host of patented delivery technologies help us transform immediate-release dosage forms into extended-release formulations.